Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth

Back

ESC Professional Premium Access

Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth

Session: Cardiovascular risk of cancer therapy

Topic: Cardio-Oncology

Speaker: Mr B. Van Berlo (Antwerp, BE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Benji Van Berlo

University of Antwerp, Antwerp (Belgium)

0 follower

5 more presentations in this session

Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction

Speaker: Doctor E. Oikonomou (New Haven, US)

Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry

Speaker: Doctor B. Huang (Chongqing, CN)

Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.

Speaker: Doctor F. Cribari (Rome, IT)

Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023

Speaker: Doctor M. Al Qaseer (Dammam, SA)

Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis

Speaker: Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Access the full session

Cardiovascular risk of cancer therapy

Speakers: Mr B. Van Berlo, Doctor E. Oikonomou, Doctor B. Huang, Doctor F. Cribari, Doctor M. Al Qaseer...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources